The CoronaVac COVID-19 vaccine developed by China’s Sinovac Biotech Ltd showed efficacy between 50% and 90% in Brazilian trials, Sao Paulo’s state health secretary said, and its Brazilian producer said full trial results will be released by Jan…
CoronaVac efficacy at 50-90% in Brazilian trial – Sao Paulo official
